Replimune Group Inc (NASDAQ:REPL), a biotechnology company specializing in oncolytic immunotherapy for cancer treatment with a current market capitalization of $803 million, has been making ...
Industrial Alliance Insurance and Financial Services Inc. (TSX:IAG), commonly known as iA Financial Group, stands as a ...